Skip to main content
GL Pharm Tech Corp. logo

GL Pharm Tech Corp. — Investor Relations & Filings

Ticker · 204840 ISIN · KR7204840003 KO Manufacturing
Open in API
Filings indexed 260 across all filing types
Latest filing 2024-03-13 Major Shareholding Noti…
Country KR South Korea
Listing KO 204840

About GL Pharm Tech Corp.

http://www.glpt.co.kr/

GL Pharm Tech Corp. is a pharmaceutical company specializing in the development of incrementally modified drugs (IMDs). The company focuses on creating improved versions of existing pharmaceutical products by utilizing advanced drug formulation and delivery technologies. Its core mission is to enhance the therapeutic value and safety of marketed drugs, with a specific emphasis on reducing side effects and improving patient convenience. GL Pharm Tech is actively engaged in research and development, managing a pipeline of drug candidates and conducting clinical trials to support the commercialization of its enhanced pharmaceutical products.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details changes in share ownership by a major shareholder (Ideal Private Equity Fund) in a listed company (GL PharmTech). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-03-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details a change in shareholding by a major shareholder (W Science Co., Ltd.) in GL PharmTech. This type of filing is specifically used to report significant changes in share ownership by major shareholders or insiders, which corresponds to the 'Major Shareholding Notification' category.
2024-03-12 Korean
주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for GL PharmTech. It outlines the date, location, agenda items (financial statement approval, director/auditor compensation), and information regarding electronic voting. This document serves as the official proxy solicitation and meeting notice sent to shareholders to inform them of the upcoming meeting and request their participation/votes. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2024-03-11 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for GL PharmTech. It contains the meeting agenda, details on voting procedures (including electronic voting), and management information such as director activities and financial statements. This type of document is classified as a Proxy Solicitation & Information Statement (PSI) because it provides shareholders with the necessary information to vote on matters at the upcoming meeting.
2024-03-11 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (often referred to as a Proxy Solicitation Statement). It contains information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures, and financial statements to be approved. This aligns perfectly with the 'Proxy Solicitation & Information Statement' category.
2024-03-11 Korean
기타시장안내(최대주주의의무보유관련) (최대주주의 의무보유 이헹 관련)
Major Shareholding Notification Classification · 1% confidence The document is a regulatory announcement from the KOSDAQ market regarding a company's (GL PharmTech) compliance with mandatory share holding requirements for its largest shareholder. It is a regulatory notice issued by the exchange or the company to inform the market about compliance status and potential future risks (investment caution designation). It does not fit into specific categories like financial reports, dividends, or director dealings, making it a general regulatory filing.
2024-03-08 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.